Latest Event Updates
3D Printing Market in Emerging Economies is Expected to Reach $4.5 Billion by 2020 – Allied Market Research
A new report by Allied Market Research titled, “3D Printing Market in Emerging Economies (China, India, UAE, Brazil, South Africa) - Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020“, indicates that the 3D printing market in emerging economies would reach $4.5 billion by 2020 registering CAGR of 37.4% from 2014 to 2020. The additive manufacturing and rapid prototyping process adopted by the leading manufacturing companies would propel the growth of the 3D printing technologies. Amongst the emerging markets, India and China are the most opportunistic regions for the development of 3D printing; therefore, market leaders are looking to capitalize on the prevailing opportunities in these countries.
Higher accuracy, faster processing, efficient use of materials and the ability to build customized products optimally are the prime elements of growth for 3D printing market. Favourable initiatives by the governments in the emerging economies are contributing to the growth of the start-ups in the region giving them power to compete with the top players in the region. According to AMR analysis on the emerging sectors, the adaptation can be phrased in simple form as “Print what you think with the help of 3D printing technology effectively”. Shanghai Winsun Decoration Design Engineering, a Company based in China, has adopted Contour Crafting to build houses which is a milestone to a lot of companies. Unique factors of 3D printing over traditional printing processes such as building complex designs easily, mixing of materials to meet continuously changing demands of customers, effective time management, among others have been the prominent factors driving the adoption of 3-D printing.
Get the full access of the report at http://www.alliedmarketresearch.com/3D-printing-emerging-economies-china-india-UAE-brazil-south-africa-market
The easy portability and simple installation with the facility of mixing different types of materials according to need of the operating environment has made 3D printing a popular technology. The widespread adoption of 3D printers in healthcare and medical sectors in emerging economies is bringing the technology into the limelight among the domestic players. The technology is gaining prominence amongst leading domestic players, as the products manufactured can be further used in varied applications.
AMR analysis suggests that the commercialization of 3D printing technology would not only lower manufacturing material loss and minimise the labour cost, but also raise awareness and eventually lead to widespread adoption of the technology. Mergers and acquisitions among top global players and local players of emerging regions would further accelerate the growth and adoption of the technology. Acquisition of Brazilian domestic company named Robotech by 3D Systems; a global leader is one such notable example that confers the impending market trend.
The initiatives taken by governments across the emerging economies to enhance the 3D printing technology is one of the major driving factors. In April 2013, China has invested $6.5 million to conduct research on key 3D printing technologies. Technological events have been arranged across sectors for spreading awareness among stakeholders.
The adoption of the technology would lead to low labour cost and efficient use of printing material, which would give a competitive edge to manufacturing companies. General Electric, on the other hand, explored the potential in the Indian market by incorporating additive manufacturing technology in manufacturing plastic parts and eventually also used the technology in manufacturing metal parts. Key companies profiled in the report are StratasysLtd, 3D Systems, Arcam AB, Autodesk Inc., ExOne Company, Voxeljet AG, Optomec Inc., Hoganas AB, Organovo Holdings Inc., and Ponoko.
According to a new market research report by Allied Market Research titled, “Global Light Emitting Diode (LED) Market (Technology, Application and Geography), 2013 – 2020″ the global LED (chips and components) market is forecast to reach $42.7 billion by 2020, registering a CAGR of 13.5% from 2014 to 2020. Asia Pacific commands dominance of the LED technology market. The region houses approximately 3/4th of the global electronics manufacturing industries. North America, due to its high-tech forensic and medical applications leads the market for UV LEDs.
After the grand success of the CFL lights, light emitting diode is the next buzzing technology in the general lighting industry. Absence of hazardous liquid mercury and power efficiency has allowed LED to successfully penetrate the market and has outdone CFL lighting in the commercial market. It is anticipated that LED lights would command about 20% share of the global lighting market by 2020. This will be equivalent to 2/3rd of the revenue for LED. However, the demand for basic LED in backlighting applications would decline as OLED broadens its horizon of applications and would eventually supersede basic LED based mobile displays.
To View the complete report, visit the website at http://www.alliedmarketresearch.com/LED-light-emitting-diode-market
UV LED primarily finds its application in medical treatments and forensic tests. UV LED technology anticipates further development as companies are rigorously working out acquisitions to expand their product portfolio and applications. In January 2013, Noblelight acquired Fusion UV, manufacturer of UV LED technology to enhance their UV LED product features. Developed regions, though, are early adopters of the UV LED technology; the healthcare sector in developing regions such as Asia Pacific is also contributing to the growth of the technology. The growing medical tourism and lower cost of treatments will strengthen the adoption of UV LED technology in developing regions.
Foreseeing great environmental benefits and energy saving capabilities government across the globe are implementing LED lighting in most of the public settings. The U.S. government has already started replacing the conventional street lights with LED’s, which is anticipated to complete by the end of 2014. Such developments are and will be instrument in the growth of the LED technology market. “The growth in revenue will be slower than the rise in unit sales of LEDs due to the constantly declining price of LEDs; however, the overall market would grow at a constant pace due to growing demand for LEDs and expanding applications” states AMR analyst Ranjan Singh. “Continuous development in the technology suggests huge underlying potential for OLEDs during the forecast period,” adds the analyst citing the recent rollouts of OLED mobile handsets by Samsung and Nokia. High brightness (HB) LEDs hold nearly 60% of the market share as it can provide much brighter light with lower voltages as compared to other market alternatives. The rapid growth in 4K TV segment suggests that HB LED will continue to hold the key to the growth of LED technology market. Major companies such as Samsung SDI and RIT Display are investing substantially on the development of advanced OLED display technologies.
Rising application of LED in general lighting has compelled the manufactures to concentrate on the launch of new LED lighting products and expand their production. OSRAM opened its LED assembly plant in Wuxi,China, to expand its fully loaded LED capacities and also to strengthen its market position in the global LED market. The company has chosen the plant location in China to capture the highly potential Asian market. The notable players in this space include and profiled in the are American Bright Optoelectronics Corps, Cree Incorporation, International Light Technologies, Ledtronics, Philips Lumileds Lighting Company, Samsung Electronics Co. Ltd., Seoul Semiconductor Co. Ltd., OSRAM Licht AG, Nichia, LG Innotek Co Ltd., GE Lighting Solutions and Toyoda Gosei Co., Ltd. Nichia, Samsung, and Osram held nearly 35% share in the global LED market revenue in 2013.
RNA Therapeutics Market is Expected to Reach $1.2 Billion, Globally, by 2020 – Allied Market Research
A new report by Allied Market Research, titled “RNA Therapeutics Market (technology, applications, end user and geography) – Industry Analysis and Forecast, 2013 – 2020″, suggests that the RNA Based Therapeutics Market would reach $1.2 billion by 2020 registering a CAGR of 28.4% during 2014 – 2020. Due to its ability to render targeted solutions for chronic diseases such as cancer, AIDS, rare genetic disorders, and certain cardiovascular conditions, RNA based therapeutics is expected to significantly impact the global pharmaceutical industry.
The large scale funding from public and private sector, growing interest of pharmaceuticals and biotech giants for developing novel delivery technology, and anticipated saving in healthcare expenditure are propelling the growth of RNA therapeutics market. Moreover, the platform technologies such as RNAi and antisense have enabled researchers to accelerate their research activities by defining gene sequences for chronic diseases. Companies have widened the research focus on RNA based drug as well, which has fueled the growth of the overall RNA therapeutics market.
To View the complete report, visit the website at http://www.alliedmarketresearch.com/RNA-based-therapeutics-market
Pharmaceutical companies have identified the RNA therapeutics for variety of chronic diseases and are also exploring the potential of RNA technology for diagnostic purposes. The RNA based therapeutics market, in the near future is likely to witness a substantial level of momentum due to government funding and programs aimed at commercialization of these drugs. The government of United States, through its National Institute of Health (NIH), provides funds for RNA therapeutics research, thus assist in propelling the growth of this market. To boost the research activities the U.S. FDA is providing fast track designation to the RNA products, which are in the pipeline.
The study suggests that the enabled technologies such as RNA interference technology (RNAi) and RNA antisense technology will dominate the market with RNAi technology getting interest from most of the participants. The development pipeline suggests that oncology segment will emerge as the largest application segment. This is largely due to the high prevalence of such diseases and limited efficiency of available therapeutics in treating such diseases. Research and therapeutics are the two major end-use segments for RNA therapeutics market. North America currently commands the lion’s share of the market as most of the research and development activity is concentrated in this region. However, Asia Pacific and other emerging regions will gradually catch-up over the forecast period.
The Key companies in this space are Alnylam Pharmaceuticals, Inc., Benitec Biopharma Limited, Cenix BioScience GmbH, Dicerna Pharmaceuticals, Inc., Genzyme Corporation, ISIS pharmaceuticals Inc., Quark Pharmaceuticals, Inc., Silence Therapeutics PLC, and Tekmira Pharmaceuticals Corp. These organizations have raised funds from private and public sectors to bear the high cost of RNA therapeutics research. Though the clinical results behind RNA based therapeutics are compelling, the Pharma and biotech companies are still working to identify opportunistic areas to grow. It is most likely that the RNA therapeutic companies would successfully tackle the drug delivery issue, which is the major hurdle in commercialization of this therapeutics and at the same time would reap benefits.
According to a new market research report by Allied Market Research titled, “Global Shale Gas Market (Technology, Application and Geography) – Industry Analysis, Trends, Share, Opportunities and Forecast, 2013 - 2020“ the global shale gas market is forecast to reach $104.1 billion by 2020, registering a CAGR of 9.3% during the forecast period (2014 – 2020). The corresponding volume consumption will reach 19,619.4 bcf in the same year. The advent of hydraulic fracturing and horizontal drilling techniques has nearly doubled the efficiency of shale gas retrieval from plays, revolutionizing the shale gas market. China is a major Asian country to propel the demand aided by insatiable energy needs and increasing dependence on natural gas.
“Shale gas, as potent alternative source of natural gas, is expected to shake up the global energy market in the coming years. The availability of large number of shale plays, which is estimated at 6,148 tcf in total, is presenting opportunity for marketer”, state AMR analysts Apurva Sale and Guru Mallick. “Technological advancements vis-à-vis the exploration and extraction of shale gas are enabling corporations to gain strategically advantageous positions in the competitive market”, add the analysts. Though the large number of shale gas reserves are available across the world, (North America 1685 tcf, South America 1430 tcf, Europe 470 tcf, Middle East and Africa 1393 tcf, and Asia-Pacific 1170 tcf), exploration and extraction still remains the major challenge in most of the regions due to high extraction cost and large amount water usage in conventional processes. The technological trend such as hydraulic fracturing and horizontal drilling for the extraction of the shale gas are contributing to the rise in the production of shale gas in various geographies. As shale plays are available in abundance and almost equally across the regions, the mass production will lower dependence on fossil fuel reserves which is available only in specific region. More energy independence with shale gas adoption will eventually lead to better economic stability of the country.
To View the complete report, visit the website at http://www.alliedmarketresearch.com/shale-gas-market
Despite the latent commercial potential, the regulatory issues in various regions would impede market growth. According to UK government, fracking would be impractical in the parts of UK due to the scarcity of the water supplies. Amidst, various European countries such as Poland, United Kingdom, and Algeria would start the production of shale gas in next two to three years with the help of advance extraction technology.
Shale Gas has a wide ranging application in power generation, industrial usage, residential and commercial utility and usage in transportation. The power generation sector would benefit the most from the adoption of shale gas as it would be a cost-effective alternative that ensures reduced electricity costs.
The worldwide adoption of shale gas as an energy resource would undoubtedly benefit every region. The usage of unconventional energy resource is an upcoming trend in the energy industry. A substantial number of shale reserves in countries such as China,Argentina and Algeria would act as a golden opportunity for companies to enter the shale gas market. The Asia Pacific region appears especially attractive due to the up gradation of technology for the extraction of shale gas and the significant number of shale reserves. In-spite large availability of shale reserves in the European countries the production and adoption would be at lower side due to stringent regulatory hurdles.
Key players such as Baker Hughes Incorporation, Anadarko Petroleum Corporation, BHP Billiton Limited, Royal Dutch Shell, ConcoPhillips, ExxonMobil & Chesapeake Energy Corporation and the developmental strategies adopted by them have been carefully examined. Acquisitions, expansions, partnerships, collaborations and joint ventures are some major strategies adopted by market players in order to sustain in the competitive market.
Hadoop-as-a-Service (HaaS) Market is Expected to Reach $16.1 Billion Globally by 2020 – Allied Market Research
According to the latest report by Allied Market Research titled, “Global Hadoop-as-a-Service (HaaS/HDaaS) Market (Deployment Type, End User, Geography) – Industry Analysis, Trends, Share, Opportunities and Forecast, 2013- 2020″, the global HaaS market is expected to reach $16.1 billion by 2020, registering a CAGR of 70.8% from 2014 to 2020. In the current business scenario, HaaS market is majorly constricted to North America. Amazon Elastic Map Reduce was the most prominent service, accounting to nearly 85% of the global market revenue in 2013.
HaaS made a grand ingress in the big data analytic market in last couple of years. The advent of this novel technology is highly appreciated among the data scientists and among the SMEs. The market has doubled itself in 2013 (from 2012) and is now gaining prominence among conventional Hadoop users. Noteworthy, Hadoop-as-a-service is expected to give a tough competition to on-premises-Hadoop in the coming years. The outburst of HaaS is anticipated to overcast the growth of the on-premises Hadoop market through 2020. With an optimistic view, AMR analysts further predict that the market would witness a strong bullish run during 2020 – 2025.
Browse the full report with TOC(Table of Contents) at http://www.alliedmarketresearch.com/hadoop-as-a-service-market
“Hadoop in the Cloud” (HaaS/HDaaS) holds numerous benefits over conventional Hadoop. Low upfront cost (for both run it yourself and pure play HaaS) and non-technical interface (in case of pure play) are the crucial dynamics propelling the market. Many providers are coming up with graphic and excel based interfaces, which makes Hadoop operations easier than ever. HaaS adds flow to business operations as providers take sole responsibility of running and managing Hadoop jobs. SMEs, social media firms, SaaS providers. Gaming companies are largely contributing to HaaS revenue, and the growing demand for HaaS by these business entities is further fuelling the market.
Persisting security concerns and lack of awareness among end users are the only pullbacks for the market growth. Information technology is acting as a boon in creating HaaS awareness among target customers. Persisting security concerns are also anticipated to die down to an extent due to the adoption of private clouds and high security cloud storages. AWS has already made a move in this direction with “AWS GovCloud (U.S. region)” that complies with the U.S. International Traffic in Arms Regulations (ITAR) requirements.
The evolution of smaller pure play/managed HaaS players, despite the presence of giants such as IBM and Microsoft, has grabbed the attention as these smaller players are making strong inroads to the market. However, AWS has been a common storage platform for most of these HaaS providers. Cloudera, one of the leaders in Hadoop, offers CDH3 as a HaaS offering. Microsoft Corporation, IBM Corp., Amazon Web Services, Cloudera, Inc., Datameer, Inc., Hortonworks, MAPR Technologies, Emc Corp., Mortar Data Inc. and Altiscale are among key market participants analyzed in this report.
This report by Allied Market Research is the latest in the Hadoop market research reports series and provides answers to a number of questions as below; however, not limited to:
- How is the HaaS going to shadow on-premises-hadoop?
- What verticals are most adopters of HaaS and what will be the future scenario?
- Which deployment type is currently most profitable and what are the future prospects?
- Who is ripping the early-mover advantage? Who would be the leader in future?
- Where is the money and growth?
The new report by Allied Market Research titled, “DNA diagnostics Market (products, applications, techniques, end users and Geography) Global Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020,” indicates that the global DNA diagnostics market would reach $19 billion by 2020 registering a CAGR of 9.8% from 2014 to 2020. The potential to provide accurate diagnosis and cost effectiveness over alternative diagnostic techniques are factors which supplement the growth of the DNA diagnostics market.
The latest figures suggest that approximately 8.2 million people are living with cancer and 39 million with HIV. These numbers are set to increase consistently; however, advanced automated DNA diagnostics technologies such as next generation sequencing could play a crucial role in diagnosing and curbing these diseases. “Next generation sequencing has had a significant impact on diagnostic procedures and is set to gain momentum in the foreseeable future.”, states AMR analyst Sharayu Dhabale. “Next generation sequencing not only reduces the cost of sequencing, but increases the throughput as well; it could thus help in bridging the gaps in traditional and personalized medications”, adds the analyst. This makes it a promising investment opportunity for key players. Illumina Inc’s new cost-effective genome machine HiSeq X Ten -the world’s first DNA crunching supercomputer- is leading to a significant reduction in the price of sequencing a human genome.
To View the complete report, visit the website at http://www.alliedmarketresearch.com/DNA-diagnostics-market
AMR analysis suggests that the tremendous potential of novel DNA diagnostic technologies and the probability of them being adopted in personalized medicines has not only reduced the expenditure in diagnostic procedures but has also helped in increasing the efficiency of chronic disease identification. Furthermore, the emergence of personalized medicines and the rising number of initiatives vis-à-vis product development and clinical trials from key players has laid the groundwork for DNA diagnostics technologies. Various technologies such as PCR, sequencing technology, microarray, in situ hybridization and mass spectrometry are considered in this report, with special emphasis on key market trends and their growth potential. Given its wide scope of application in almost all activities related to DNA diagnostics, the polymerase chain reaction (PCR) technology holds the largest share of DNA diagnostics market revenue.
Market analysis in terms of geography suggests that developed economies would retain their dominance in the market. This could be attributed to the early adoption of the technology due to potential reduction offered by DNA diagnostic to their high healthcare expenditure. However, developing economies, such as in Asia-Pacific, will significantly influence the DNA diagnostic market during the extended forecast period (2020-2025), largely due to potential growth in per capita healthcare expenditure and very large undiagnosed population.
Several companies operating in this region are seeking novel technologies to gain traction in the competitive market. Product launch is the key strategy adopted by companies operating in this market. These companies are developing novel products for the treatment of various diseases such as infectious diseases, cancer, prenantal diagnosis, pre-implantation diagnostics and myogenic disorder. Additionally, these companies are also adopting collaboration and acquisition to retain their respective positions and to gain traction in the market. Key companies profiled in the report are Bayer Diagnostic, Sysmex, Roche Diagnostics, Abbott laboratories, Cephide, Gene-probe Inc., Illumina, Inc., Thermo Fisher Scientific, Bio-Rad Laboratories, Johnson and Johnson, and Novartis.
According to a new report by Allied Market Research titled, “Global Graphene Market (Bulk material, Film, Product Type, Applications, Geography) – Industry Analysis, Trends, Share, Opportunities and Forecast, 2013- 2020″, the global graphene market is expected to reach $149.1 million by 2020, registering a CAGR of 44.0% from 2014 to 2020. North America is and will be the largest Graphene market through 2020. Asia Pacific is anticipated to be the fastest growing region with a CAGR of 42.9% due to high growth of electronics and automotive industries, which are among top consumers of Graphene. In terms of volume, 1.8 kilo tons of Graphene bulk and 26.7 million square cm of Graphene films will be consumed by 2020.
Browse the full report with TOC at http://www.alliedmarketresearch.com/graphene-market
Graphene has been justly conferred the title of ‘Wonder Material’ owing to its exceptional strength and thinness. Characteristics such as mechanical strength (200 times stronger than steel), electrical and optical properties, ensures that Graphene has wide application in energy, automotive, aerospace, electronics, biomedical, and such others. Latterly, product and technology development is on the rise that is evident by the fact that about 3,018 Graphene patent applications were granted by July 2011 that almost tripled to 8,413 byFebruary 2013. Moreover, the European Union has created a Flagship program for graphene, allocating about $1.3 billion to spend on the development of Graphene over the next 10 years. Such movements are instrumental in allowing commercial parity and faster growth of the Graphene market.
Majority of the companies involved in the Graphene business have employed product launch as their primary business strategy, particularly concerning monolayer & bi-layer graphene, Graphene Oxide (GO) and graphene nano platelet (GNP). Unfortunately, high-priced equipment and incapability of mass production are factors which restrain the growth of the market. Nonetheless, chemical vapor deposition (CVD) is rendering better production capabilities to counter mass production issues. Graphene counterparts such carbon nano tubes (CNT) and nanoclays are presenting stiff challenge; however, Graphene stands price competitive with CNTs and tops in performance when compared to nanoclays. As mass production increases, there is potential for 70% to 80% price drop, making Graphene far competitive to its counterparts.
Key products, such as GNP, is one of the potential segments in the overall market owing to its low cost, early adoption and application in graphene based composites. GO and monolayer & bi-layer graphene will emerge as lucrative segments in the long run due to their usage in large applications, chiefly in electronics, energy, aerospace and coatings. Few layer graphene has not yet received substantial attention, due to higher prices with low volume production. Graphene electronics and energy storage remains most popular application markets due to the early adoption by players in aforesaid industries.
Key graphene producers such as CVD Equipment Corporation, Graphene Nanochem PLC, Vorbrck Materials, XG Sciences, Haydale Limited, Graphenea, Graphene Laboratories, Bluestone Global Tech, Angstron Material, Inc. and ACS Material, LLC have adopted product development and agreement as their key developmental strategies to gain competitive edge in the graphene market.